Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Theralase Technologies Inc. V.TLT.W


Primary Symbol: V.TLT Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Recent & Breaking News (TSXV:TLT)

IIROC Trade Halt - Theralase Technologies Inc.

Newsfile August 27, 2013

Theralase Releases Financial Results for First Quarter 2013

TheNewsWire May 30, 2013

Theralase Launches New Head Office and Therapeutic Laser Centre

TheNewsWire May 28, 2013

Theralase Advanced Cancer Therapy Research Recognized at Major International Conference

TheNewsWire May 16, 2013

Theralase Announces 2012 Year End Financials; Theralase Advances Therapeutic Laser and Cancer Destruction Technologies

TheNewsWire May 1, 2013

Theralase's Innovative Anti-Cancer Technology Validated at Major International Conferences

TheNewsWire April 19, 2013

Theralase Applies to TSX Venture Exchange for Warrant Extension

TheNewsWire March 28, 2013

Theralase Achieves Commercialization Milestone For Its Bladder Cancer Therapy

TheNewsWire March 14, 2013

Theralase Expands Board of Directors with Strong Financing Capabilities

TheNewsWire February 1, 2013

Renowned Oncologist Dr. Michael Jewett Joins Theralase's Medical and Scientific Advisory Board

TheNewsWire January 29, 2013

Junior miner powers higher on gold mines acquisition

Sean Mason March 28, 2012

Junior explorer surges on copper results

Sean Mason January 5, 2010